Indications and uses
Temporarily relieves: ° hay fever or other upper respiratory allergies like: ° runny nose ° sneezing ° watery eyes ° itchy nose or throat
Temporarily relieves: ° hay fever or other upper respiratory allergies like: ° runny nose ° sneezing ° watery eyes ° itchy nose or throat
° take every 4-6 hours ° do not take more than 6 doses in 24 hours. Adults & children 12 years & over: 1-2 capsules Children 6 to under 12 years: 1 capsule Children under 6: ask a doctor
Diphenhydramine HCl 25mg
Diphenhydramine HCl 50mg
Antihistamine
Temporarily relieves: ° hay fever or other upper respiratory allergies like: ° runny nose
° sneezing ° watery eyes ° itchy nose or throat
Do not use with any other product containing Diphenhydramine HCl, including one applied topically.
Ask a doctor or pharmacist before use if you have ° trouble urinating due to enlarged prostate gland ° a breathing problem such as emphysema or chronic bronchitis ° glaucoma ° if you are taking sedatives or tranquilizers
When using this product ° avoid alcoholic drinks ° marked drowsiness may occur ° excitability may occur, especially in children ° alcohol, sedatives & tranquilizers may increase drowsiness ° be careful when driving a motor vehicle or operating machinery.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
° take every 4-6 hours
° do not take more than 6 doses in 24 hours.
Adults & children 12 years & over: 1-2 capsules
Children 6 to under 12 years: 1 capsule
Children under 6: ask a doctor
Store at room temperature 15°-30°C (59°-86°F)
Protect from excessive moisture
Lactose Monohydrate, Silicon Dioxide, Magnesium Steareate, Black Iron Oxide, Gelatin, Sodium Lauyl Sulfate, D&C Red No. 28, FD&C Red No. 40, FD&C Blue No. 1.
Distributed by:
SDA Laboratories, Inc.
Greenwich, CT 06830
Repackaged by:
Rebel Distributors Corp
Thousand Oaks, CA 91320
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21695-304-15 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| 21695-304-20 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| 21695-304-24 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| 21695-304-30 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| 21695-304-90 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| 21695-500-15 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| 21695-500-20 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| 21695-500-30 | 2019-09-24 | C162847 | 48780-1 | 934fe258-4d4f-48b1-e053-8cdaa90a720a | Diphenhydramine Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21695-304-15 | Diphenhydramine | 15 in 1 BOTTLE | CAPSULE | 15 | 1 | |
| 21695-304-20 | Diphenhydramine | 20 in 1 BOTTLE | CAPSULE | 20 | 1 | |
| 21695-304-24 | Diphenhydramine | 24 in 1 BOTTLE | CAPSULE | 24 | 1 | |
| 21695-304-30 | Diphenhydramine | 30 in 1 BOTTLE | CAPSULE | 30 | 1 | |
| 21695-304-90 | Diphenhydramine | 90 in 1 BOTTLE | CAPSULE | 90 | 1 | |
| 21695-500-15 | Diphenhydramine | 15 in 1 BOTTLE | CAPSULE | 15 | 1 | |
| 21695-500-20 | Diphenhydramine | 20 in 1 BOTTLE | CAPSULE | 20 | 1 | |
| 21695-500-30 | Diphenhydramine | 30 in 1 BOTTLE | CAPSULE | 30 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 21695-304 | DIPHENHYDRAMINE CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | Legacy NDC, 5 package rows | 20110223_c46e1443-dffe-47a9-bc9a-acbe3a8b0b41.zip |
| 21695-500 | DIPHENHYDRAMINE CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | Legacy NDC, 3 package rows | 20110223_c46e1443-dffe-47a9-bc9a-acbe3a8b0b41.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | ACTIVE INGREDIENT | TC2D6JAD40 | 1 | |
| DIPHENHYDRAMINE | ACTIVE MOIETY | 8GTS82S83M | 1 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 21695-304 | 21695-304-15, 21695-304-20, 21695-304-24, 21695-304-30, 21695-304-90 |
| 66424-020 | |
| 21695-500 | 21695-500-15, 21695-500-20, 21695-500-30 |
| 66424-021 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE / ORAL | 16 mg | ||
| D&C RED NO. 28 | D&C RED NO. 28 | 767IP0Y5NH | CAPSULE / ORAL | 1 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE / ORAL | 10932 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE / ORAL | 11 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE / ORAL | 26.3 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE / ORAL | 600 mg | ||
| D&C RED NO. 28 | D&C RED NO. 28 | 767IP0Y5NH | CAPSULE / ORAL | 1 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE / ORAL | 600 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE / ORAL | 11 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE / ORAL | 26.3 mg | ||
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE / ORAL | 16 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CAPSULE / ORAL | 3990 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE / ORAL | 10932 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | CAPSULE / ORAL | 3990 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | SDA Laboratories, Inc. | 437e6a13-a4ff-4f98-8973-042f224ee85e | 2025-01-13 | Warnings | 66424-021 |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | SDA Laboratories, Inc. | 6a520986-1004-4ee6-9a47-1dfd90bb1b2c | 2025-01-13 | Warnings | 66424-020 |
| c46e1443-dffe-47a9-bc9a-acbe3a8b0b41 | c46e1443-dffe-47a9-bc9a-acbe3a8b0b41 | 2011-02-15 | Warnings | c46e1443-dffe-47a9-bc9a-acbe3a8b0b41 c46e1443-dffe-47a9-bc9a-acbe3a8b0b41 |
Adverse event summaries are temporarily unavailable. Other product information remains available.